Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

Recruiting

Phase 1

Phase 2

MyoblastsTransplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

Sponsor:

CHU de Quebec-Universite Laval

Code:

NCT02196467

Conditions

Duchenne Muscular Dystrophy

Eligibility Criteria

Sex: Male

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Myoblast transplantation

Saline injection

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by CHU de Quebec-Universite Laval on 2021-01-29.